Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-26 Sale |
2024-08-26 5:42 pm |
AGILE THERAPEUTICS INC | AGRX | Coiante Scott M Chief Financial Officer |
20,080 | $1.52 | $30,522 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Option Award |
2025-02-18 4:17 pm |
N/A 2035-02-13 |
LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer |
1,201,780 | $0 | 1,201,780 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-02 4:09 pm |
N/A 2035-01-02 |
LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer |
230,000 | $0 | 230,000 (Direct) |
View |
Ownership |
2025-01-02 4:06 pm |
N/A 2035-01-02 |
LEXICON PHARMACEUTICALS INC. | LXRX | Coiante Scott M SVP, Chief Financial Officer |
0 | $0 | 230,000 (Direct) |
View |
| 2023-10-03 Option Award |
2023-10-04 4:45 pm |
N/A N/A |
AGILE THERAPEUTICS INC | AGRX | Coiante Scott M Chief Financial Officer |
20,000 | $0 | 20,080 (Direct) |
View |
Ownership |
2023-08-25 4:02 pm |
N/A N/A |
AGILE THERAPEUTICS INC | AGRX | Coiante Scott M Chief Financial Officer |
0 | $0 | 80 (Direct) |
View |
| 2022-07-28 Option Award |
2022-08-01 5:00 pm |
N/A 2032-07-28 |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
150,000 | $0 | 234,265 (Direct) |
View |
| 2022-06-03 Tax Withholding |
2022-06-07 5:02 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
35,284 | $0.805 | 84,265 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 5:02 pm |
N/A 2032-03-10 |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
228,800 | $0 | 305,449 (Direct) |
View |
| 2022-02-25 Tax Withholding |
2022-03-01 5:01 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
14,817 | $1.74 | 76,649 (Direct) |
View |
| 2021-08-25 Tax Withholding |
2021-08-27 5:01 pm |
N/A N/A |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
7,534 | $3.98 | 91,466 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 7:03 pm |
N/A 2031-02-25 |
Aprea Therapeutics Inc. | APRE | Coiante Scott M SVP, Chief Financial Officer |
239,500 | $0 | 242,000 (Direct) |
View |